Abstract: The embodiment of the present disclosure provides an imaging method for a dispersion energy spectrum of surface waves, an electronic device, and a storage medium. The imaging method includes: obtaining first surface wave data, and the first surface wave data corresponding to a space-time domain representation; processing the first surface wave data to obtain the second surface wave data, and the second surface wave data corresponding to a space-frequency domain representation; and processing the second surface wave data based on a preset algorithm to obtain a first imaging result, the first imaging result corresponding to a slowness-frequency domain representation.

Abstract: Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Abstract: An optical apparatus and a near-eye display device are provided. The optical apparatus includes a light source, an angle selection unit, a light conversion unit, a first polarization unit, a second polarization unit, and a lens. The first polarization unit is disposed on a light-emitting side of the light source; a first surface of the first polarization unit faces a light-emitting surface of the light source; the angle selection unit is disposed opposite the first polarization unit; the light conversion unit is disposed on a side, away from the first polarization unit, of the angle selection unit; the second polarization unit is disposed opposite the angle selection unit; and the lens is disposed opposite the light conversion unit.

Abstract: Disclosed are a short-distance optical amplification module, method and system. The module comprises a reflective type polarizing plate, a first phase delay plate, an imaging lens, a second phase delay plate and an absorptive type polarizing plate, arranged successively. The reflective type polarizing plate is arranged on a transmission path of an optical image. The first phase delay plate is arranged on the transmission path of the optical image passing through the reflective delay plate. The imaging lens is arranged on the transmission path of the optical image. The second phase delay plate is configured for converting a polarization direction of the optical image from an elliptical or circular polarization direction to a second linear polarization direction. The absorptive type polarizing plate is arranged on one side of the second phase delay plate that faces away from the imaging lens.

Abstract: The present disclosure provides compounds according to Formula I and pharmaceutically acceptable salts thereof, as well as compositions including such compounds and a pharmaceutically acceptable carrier or excipient. Further provided are methods of inactivating SIRT6 with compounds of Formula I as well as compounds of Formula III, W2—R2—Y—R3, as described herein. In addition, the present technology provides methods of treatment using such compounds to lower LDL levels, lower triglyceride levels, and/or increase glucose tolerance in a subject, and/or to inhibit proliferation of ovarian, colorectal, hepatocellular, non-small cell lung, glioblastoma, osteosarcoma, pancreatic, and skin cancer cells, and/or inhibit liver and/or kidney fibrosis, and/or promote corneal epithelial wound healing.

Abstract: A self-assembled therapeutic dendron-micelle includes a first amphiphilic dendron-coil, a second amphiphilic dendron-coil, and optionally a third amphiphilic dendron-coil, and an encapsulated BRD4 ligand or BRD4 proteolysis targeting chimera. The first and optional third amphiphilic dendron-coils have a therapeutic peptide conjugated thereto. Also included are pharmaceutical compositions containing the dendron-micelles, methods of making the dendron-micelles, and therapeutic methods including administering the dendron-micelles to a subject in need thereof.

Abstract: An optical system and a near-eye display device are provided. The optical system includes a light-emitting source, a light conversion unit, and a first reflection unit. The light conversion unit is on a light exit side of the light-emitting source, and a first surface of the light conversion unit faces a light exit surface of the light-emitting source. The first reflection unit is on a side of the light conversion unit away from the light-emitting source, and a first angle is provided between a second surface of the first reflection unit and the first surface. A first light emitted by the light-emitting source is converted by the light conversion unit into a second light, and the second light is reflected by the first reflection unit.

Abstract: Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments.

Abstract: Compounds of the formula: pharmaceutical compositions containing the compounds, and methods of inhibiting neoplastic cell growth using the compounds and compositions.

Abstract: Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Abstract: Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Abstract: Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Abstract: Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments.

Abstract: Described is a method to make diindolylmethanes and indolyl/pyrrolylmethanes, The method includes the steps of contacting an ether comprising an arylpropargyl moiety and an amine-protected, substituted or unsubstituted aniline moiety with a substituted or unsubstituted indol or a substituted or unsubstituted pyrrole, in the presence of a metal-containing catalyst, for a time and at a temperature to cause an annulation/arylation cascade reaction that yields a diindolylmethane or a indolyl/pyrrolylmethane. The resulting compounds are effective to modulate activity of arylhydrocarbon receptors, to inhibit activity of PCSK9, and to stimulate secretion of glucagon-like peptide 1 in mammals.

Abstract: Embodiments of the present disclosure provide a motor rotor and a motor. The motor rotor includes: multiple groups of laminations having inner bores and arranged alternately in an axial direction of the motor rotor. The motor includes a stator and the abovementioned motor rotor provided in the stator. The motor rotor and the motor according to embodiments of the present disclosure, for example, may reduce installation costs of the laminations and a rotor shaft in the motor rotor.

Abstract: Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Abstract: Embodiments describe a motor. The motor includes a stator, and a rotor, which is arranged within the stator. An end part of at least one air-gap slot of the rotor has an offset with a predetermined distance and/or a predetermined angle relative to a main body part adjacent immediately to the end part. With the offset of a predetermined distance and/or a predetermined angle configured at the end part of at least one air-gap slot of the rotor, ripple torque of the motor is effectively lower down while complexity of the motor, stator or rotor will not be increased.

Abstract: Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; methods of using the composition to inhibit neoplastic cell growth in mammals, including humans.

Abstract: Disclosed are unnatural analogs of Diptoindonesin G, methods to make the analogs, pharmaceutical compositions containing the analogs, and methods of using the analogs to inhibit neoplastic cell growth.

Abstract: A stator, a motor and a compressor are provided. The stator includes a stator iron core and a winding. The stator iron core includes: an annular yoke; multiple stator teeth, near ends of the stator teeth being fixedly adjacent to an inner surface of the yoke and projecting inward towards the center of the stator iron core along a radial direction of the yoke, remote ends of the stator teeth that face inward along the radial direction defining a center hole for accommodating a rotor, and the stator teeth being spaced from each other in a circumferential direction; and multiple stator slots, each stator slot being defined between two neighboring stator teeth. The winding is wound around the stator teeth and operable for generating a rotating magnetic field. The yoke has at least two cut edges at an outer periphery thereof, disposed asymmetrically relative to the center.